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FOREWORD
W e hope you will enjoy reading this  edition of our National Center for  HIV/AIDS, Viral Hepatitis, STD, and 
TB Prevention Annual Report.  This is the sixth in 
our series of annual reports on NCHHSTP’s activi-
ties.  It contains brief highlights of the center’s key 
goals and some of our noteworthy accomplish-
ments from 2012.  
The epidemics of HIV and other STDs, viral  
hepatitis, and TB are large and complex, but we 
have made progress in the last year, including  
the following:
 ● Issuing recommendations that call for one-time 
routine testing of all Americans born during 
1945–1965 for hepatitis C, as those in that age 
group are five times more likely to be infected 
with the hepatitis C virus. 
 ● Publishing new guidelines for treatment of gon-
orrhea, in response to trends in laboratory data 
showing that the antibiotic cefexime is becom-
ing less effective in treating gonorrhea.
 ● Continuing the Act Against AIDS campaign 
with launches of  Let’s Stop HIV Together—a  
new HIV awareness and anti-stigma campaign 
featuring individuals with HIV who share their 
personal stories—and Take Charge, Take the 
Test, a new HIV testing campaign for African 
American women. 
 ● Releasing the 2011 Youth Risk Behavior 
summary, which included data on the preva-
lence of youth risk behaviors across the nation. 
 ● Using innovative techniques to address TB 
disease in the United States, such as TB geno-
typing—a laboratory-based genetic analysis of 
the bacteria which is useful in identifying 
TB outbreaks.
 ● Launching a web-based, interactive tool for 
accessing HIV/AIDS, viral hepatitis, STD, and 
TB surveillance data—the NCHHSTP Atlas. 
The accomplishments highlighted are just some 
of the many strides NCHHSTP has made in cham-
pioning public health and accelerating disease 
prevention and health protection activities to fight 
these diseases.  These accomplishments would not 
be possible without our expert and exceptionally 
diverse staff of public health professionals, along 
with the collaboration of our many governmental, 
non-governmental, and private sector partners. 
You can find more information about our programs 
at http://cdc.gov/nchhstp. 
Kevin A. Fenton, M.D., Ph.D., F.F.P.H. 
Director, National Center for HIV/AIDS,  
Viral Hepatitis, STD, and TB Prevention
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T he National Center for HIV/AIDS,  Viral Hepatitis, STD, and TB Prevention (NCHHSTP) at the Centers for Disease 
Control and Prevention (CDC) saves lives,  
protects people, and promotes health equity 
through its efforts aimed at preventing HIV, viral 
hepatitis, sexually transmitted diseases (STDs), 
and tuberculosis (TB). 
The Center was established in 1994 to bring 
together most of CDC’s HIV prevention activities 
into a single, organizational home alongside STD 
prevention and TB elimination programs. In 2006, 
CDC’s Division of Viral Hepatitis joined the Center. 
In January 2012, the Division of Adolescent and 
School Health (DASH) officially joined NCHHSTP.  
DASH’s mission is to prevent HIV, other STDs, and 
teen pregnancy and to promote lifelong health 
among youth. 
The infectious diseases NCHHSTP focuses on 
share similar or overlapping at-risk populations—
including racial and ethnic minorities, men who 
have sex with men (MSM), and injection drug 
users. These diseases also share similar social 
determinants, including poor access to health care, 
stigma, discrimination, incarceration, homeless-
ness, and poverty. 
To address these overlapping health issues, 
NCHHSTP applies well-integrated, multidisci-
plinary programs of research, surveillance, risk-
factor, and disease intervention and evaluation. 
The Center’s established strategic plan guides its 
programs and research by outlining key priorities 
for our work.  Below are highlights and accom-
plishments from 2012 related to specific  
priority areas.
PREVENTION THROUGH HEALTHCARE
One way that NCHHSTP interacts with the health 
care system is by issuing guidelines and recom-
mendations related to the prevention and treat-
ment of HIV/AIDS, viral hepatitis, STDs, and 
TB. NCHHSTP serves in a vital role in advancing 
strategic prevention priorities for these diseases 
through such guidance documents aimed at health 
care providers. In 2012, CDC released several 
major NCHHSTP guidelines and recommenda-
tions, including: 
 ● “Recommendations for the Identification of 
Chronic Hepatitis C Virus Infection Among  
Persons Born During 1945–1965,” Morbidity 
and Mortality Weekly Report (MMWR).
 ● “Interim Guidance for Clinicians Consider-
ing the Use of Preexposure Prophylaxis for the 
Prevention of HIV Infection in Heterosexually 
Active Adults,” MMWR.
 ● “Update to CDC’s Sexually Transmitted 
Diseases Treatment Guidelines, 2010, Oral 
Cephalosporins No Longer a Recommended 
Treatment for Gonococcal Infections,” MMWR.
 ● Updated CDC “Recommendations for the 
Management of Hepatitis B Virus-Infected 
Health-Care Providers and Students,” MMWR.
 ● “Recommendations for Use of an Isoniazid-
Rifapentine Regimen with Direct Observation 
to Treat Latent Mycobacterium tuberculosis 
Infection,” MMWR. 
 ● “Recommendations on the Use of Quadrivalent 
Human Papillomavirus Vaccine in Males— 
Advisory Committee on Immunization Practices 
(ACIP),” 2011, MMWR. 
 ● “Use of Hepatitis B Vaccination for Adults with 
Diabetes Mellitus: Recommendations of the 
Advisory Committee on Immunization Practices 
(ACIP),” MMWR.
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Another activity related to prevention through 
healthcare which NCHHSTP initiated in 2012 is an 
HIV testing project involving community phar-
macies and retail clinics.  Millions of Americans 
visit pharmacies every week, and an estimated 
30 percent of the U.S. population lives within a 
10-minute drive of a retail clinic.  
Recognizing this, NCHHSTP initiated a 2-year 
pilot project in 2012 to train pharmacists and 
retail store clinic staff at 24 rural and urban sites 
with high HIV prevalence or significant HIV testing 
needs to deliver confidential rapid HIV testing.  
The goal of the initiative is to extend HIV testing 
and counseling into the standard services offered 
by pharmacies and retail clinics. Results will be 
used to develop a model for implementation of 
HIV testing in these settings across the country. 
Other highlights of activities related to prevention 
through health care include:
 ● Release of Next Steps—Prevention of HIV/AIDS, 
Viral Hepatitis, STDs, and TB through Health 
Care: Supporting Health Departments, which 
summarizes steps NCHHSTP can take to assist 
health departments in dealing with health care 
changes that impact health departments’ deliv-
ery of prevention services. The document stems 
from an NCHHSTP consultation held in June 
2011, with participation from health depart-
ment officials, representatives of national 
organizations, federal agencies, academics, and 
other partners.
 ● Collaboration with the Health Resources and 
Services Administration (HRSA) to support 
partnerships between state health departments 
and community health centers to improve the 
quality and coordination of care for those with 
HIV, AIDS, viral hepatitis, STDs, or TB. 
PROGRAM COLLABORATION AND SERVICE 
INTEGRATION
The Center launched the NCHHSTP Atlas—a web-
based, interactive tool that allows users to create 
maps, charts, and tables using HIV/AIDS, viral 
hepatitis, STD, and TB surveillance data. The new 
application is designed to enhance access to public 
health data across NCHHSTP programs. The Atlas 
presents surveillance data for HIV, AIDS, chla-
mydia, gonorrhea, syphilis, tuberculosis, and viral 
hepatitis. Thousands of users access the Atlas each 
month. Its web address is  
http://www.cdc.gov/nchhstp/atlas/.
Other PCSI activities for 2012 included:
 ● Release of a funding opportunity announce-
ment for integrated HIV/AIDS, viral hepatitis, 
STD, and TB prevention and control activi-
ties in the U.S.-affiliated Pacific Islands. The 
funding opportunity streamlines the required 
activities for grantees, reduces reporting 
burden, and allows for more efficient use of 
resources. The six jurisdictions eligible for 
funding are the Commonwealth of the North-
ern Mariana Islands, American Samoa, Guam, 
the Federated States of Micronesia, the Repub-
lic of the Marshall Islands, and the Republic 
of Palau. The integrated announcement aims 
to address some of the challenges of disease 
burden, remote geographic locations, broadly 
dispersed populations, lack of local resources, 
and difficulty accessing medications and lab 
facilities. The funds are to be awarded by the 
end of calendar year 2012. 
 ● Continuation, in six jurisdictions that receive 
funding for PCSI demonstration projects, to 
implement their service and system integration 
activities. These jurisdictions are New York City, 
North Carolina, Philadelphia, San Francisco, 
Texas, and Washington, D.C. In San Francisco, 
the PCSI project team has established inte-
grated guidelines for preventive services for 
patients with HIV, STDs, hepatitis B and C, and 
tuberculosis. A recent PCSI activity in Phila-
delphia was the development of a Facebook 
campaign focusing on HIV and STD prevention 
targeting youth. In its first 3 months, the Face-
book ads reached over 200,000 people.   
 ● Convening of surveillance experts from around 
the country to discuss the future of case surveil-
lance systems for HIV, viral hepatitis, STDs, and 
TB. The participants recommended ways to 
increase the efficiency and reduce the burden 
of surveillance data collection and harmonize 
surveillance collection across the disease areas. 
 ● Publication of “Integrated Prevention Services 
for HIV Infection, Viral Hepatitis, Sexually 
Transmitted Diseases, and Tuberculosis for 
Persons Who Use Drugs Illicitly: Summary 
Guidance from CDC and the U.S. Department 
of Health and Human Services.” This Guidance 
was published in CDC’s MMWR in Novem-
ber 2012. NCHHSTP led the development of 
the report, which summarizes guidelines and 
recommendations of multiple HHS agencies 
for prevention and control of these diseases for 
persons who use drugs illicitly. 
GLOBAL HEALTH PROTECTION AND SYSTEMS 
STRENGTHENING
NCHHSTP helped launch a new Global  
Congenital Syphilis Partnership—a 3-year  
international initiative that aims to eliminate 
congenital syphilis. Worldwide, an estimated 2 
million women are infected with syphilis every year 
and over half of these women pass the disease to 
their unborn children. The initiative is a partner-
ship of the London School of Hygiene and Tropical 
Medicine, the Bill and Melinda Gates Foundation, 
Save the Children, the World Health Organization 
(WHO), and CDC. The partnership aims to intro-
duce rapid syphilis tests for screening pregnant 
women. Women who are infected can be treated 
with a single dose of antibiotic to prevent infection 
of their unborn child. 
The Center also supported data collection on 
youth risk behavior in developing countries in part-
nership with WHO and sponsored four interna-
tional workshops in 2012. The workshops helped 
develop the capacity of African and Asian coun-
tries to implement and report on Global Youth 
Risk Behavior Surveillance surveys—which collect 
data on youth health indicators.
PARTNERSHIPS
AIDS 2012—the XIX International AIDS Confer-
ence—held in Washington, D.C., was a key activity 
this year, allowing NCHHSTP to reach partners, 
and share the results of our research and preven-
tion programs. The scientific findings of NCHHSTP 
staff were presented at three conference sessions, 
in excess of 50 poster sessions and 10 oral presen-
tations or oral poster sessions. The presentations 
also highlighted the syndemics of HIV with STDs, 
hepatitis, and TB. CDC media outreach efforts 
around AIDS 2012 generated 151 unique media 
stories and 1 billion media impressions. Highlights 
of partnering  
activities include:
 ● Partnering with the Public Health Agency of 
Canada, the European CDC, and the Interna-
tional Organization for Migration to hold a 
session on “Responses to HIV and Migration in 
Western Industrialized Countries: Current Chal-
lenges, Promising Practices, Future Directions.” 
 ● Collaborating with the Pan American Health 
Organization to present a session on “Address-
ing Sexual Health and Evidence-based School 
Health Education: Evolving Opportunities.”
 ● Participating in satellite sessions sponsored by 
other organizations, such as the Global Forum 
on MSM and HIV and the AIDS Community 
Research Initiative of America.
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NCHHSTP has also continued to build public-
private partnerships through work with the CDC 
Foundation and the Viral Hepatitis Action Coali-
tion (VHAC). In 2012, VHAC expanded from 8 
supporting industry partners to 12, thus increas-
ing the coalition’s ability to help address viral 
hepatitis prevention priorities. VHAC provides 
funds for NCHHSTP’s Chronic Hepatitis B and C 
Cohort Study—a longitudinal study of persons with 
chronic hepatitis B and hepatitis C virus infections. 
VHAC also helps support the launch of the Know 
More Hepatitis awareness campaign http://www.
cdc.gov/knowmorehepatitis/ and other outreach 
efforts. 
WORKFORCE DEVELOPMENT AND CAPACITY 
BUILDING
NCHHSTP had several activities aimed at provid-
ing college students with opportunities to learn 
more about public health careers. The Center held 
a Federal Job Shadowing Day for students at Geor-
gia’s Historically Black Colleges and Universities. 
NCHHSTP also hosted the 5th annual NCHHSTP 
Summer Fellows Forum from June 13–July 25, 
2012. More than 60 fellows from Morehouse 
College’s Project IMHOTEP, the James A. Fergu-
son Fellowship Program, the Thurgood Marshall 
College Fund Summer Interns, Columbia Univer-
sity’s Summer Public Health Scholars Program, 
and the Tuskegee University Public Health Ethics 
Interns participated in this event. The Center also 
launched a pilot Coaching and Leadership Initia-
tive to build leadership, management, administra-
tive, and supervision skills for team leaders. 
NCHHSTP is working to save lives every day 
through its public health prevention initiatives  
and programs. 
CDC “VITAL SIGNS” FROM NCHHSTP
“New Hope for Stopping HIV,” December 2011 
http://www.cdc.gov/VitalSigns/HIVtesting/index.html 
“HIV Among Youth in the United States,” November 2012 
http://www.cdc.gov/vitalsigns/pdf/2010-12-vitalsigns.pdf
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SAVING LIVES
MAKING PROGRESS PREVENTING HIV
Investment in HIV prevention has contributed to dramatic reduction in the annual number of new infections since the peak of the epidemic 
in the mid-1980s and an overall stabilization of 
new infections since the mid-1990s—from about 
130,000 a year to about 50,000. While new 
infections continue at too high a level, NCHHSTP 
estimates that more than 350,000 HIV infections 
have been avoided because of the nation’s HIV 
prevention efforts. We have also seen declines in 
new infections in several key populations over time, 
including individuals who inject drugs, heterosexu-
als, and infants born to HIV-infected mothers. 
NCHHSTP provides HIV prevention leadership 
by working with community, state, national, and 
international partners in surveillance, research, 
prevention, and evaluation activities. The Center 
supports the National HIV/AIDS Strategy—a 
comprehensive roadmap for reducing the impact 
of HIV in the United States—released by the White 
House in 2010. NCHHSTP and its partners are 
working to further reduce the impact of HIV 
through a new High-Impact Prevention approach, 
which emphasizes using scalable interventions with 
demonstrated potential to reduce new infections 
in the most vulnerable populations to yield a major 
impact on the HIV epidemic. NCHHSTP has taken 
a number of steps to implement High-Impact Pre-
vention, including the following:
 ● In January 2012, NCHHSTP awarded $349 
million in funds through a new, 5-year HIV pre-
vention funding opportunity that better aligns 
funds to the current geographic burden of HIV 
in the United States. Funds were awarded to all 
50 states, eight cities, the District of Columbia, 
Puerto Rico, the U.S. Virgin Islands, and the 
six Pacific Island jurisdictions. The funds were 
allocated to individual health departments 
according to a formula based on the number of 
people living with HIV in each jurisdiction and 
better targets high-impact prevention strate-
gies, such as HIV testing and comprehensive 
prevention with HIV-infected persons.
 ● NCHHSTP continued to support Enhanced 
Comprehensive HIV Prevention Planning 
(ECHPP) demonstration projects in 12 heavily 
affected cities that represent 44 percent of 
the total U.S. AIDS cases. ECHPP funding has 
allowed local health departments to iden-
tify and implement a mix of HIV prevention 
approaches likely to have the greatest impact 
in their communities, based on the profile of 
their local epidemic and an assessment of the 
gaps in current HIV prevention programs. For 
example, in Los Angeles, the ECHPP project 
analyzed integrated HIV and STD surveillance 
data to identify five hot spots where approxi-
mately 80 percent of all HIV, syphilis, and 
gonorrhea cases are reported in the county. 
Los Angeles County is working to deliver more 
integrated health services in those areas. The 
ECHPP project in Miami focuses on five target 
areas with the highest incidence of HIV. Within 
these target areas, the project’s interventions 
focus on the populations of MSM, transgen-
dered persons, African-American MSM, Afri-
can-American women, Latino men and women, 
migrant workers, and intravenous drug users. 
CONTINUING TO REPORT LOW NATIONAL 
 TB RATES 
In September 2012, NCHHSTP released Reported 
Tuberculosis in the United States, 2011. In 2011, 
a total of 10,528 new TB cases were reported in 
the United States; the incidence rate in 2011 was 
3.4 cases per 100,000 population—a 6.4 percent 
decrease from 2010. This is the 19th consecutive 
year that the TB rate has declined, and is the result 
of a number of factors including the work of CDC 
and its partners. Some populations, however, 
remain disproportionately affected. In 2011, for 
the first time, Asians exceeded all other racial or 
ethnic groups with 30 percent of all cases—the 
largest percentage of total cases. Hispanics com-
prised the second largest group with 29 percent. 
NCHHSTP continues to use innovative techniques 
to address the TB epidemic in the United States, 
such as TB genotyping—a laboratory-based genetic 
analysis of the bacteria that cause TB disease 
(Mycobacterium tuberculosis). As TB incidence 
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declines in the United States, TB is increasingly 
found in harder-to-reach populations and 
locations—such as homeless persons or for-
eign-born persons. Genotyping has been used 
to identify outbreaks that might otherwise 
be difficult to identify. NCHHSTP supports 
the TB Genotyping Information Management 
System, which provides genotyping data that is 
accessible to public health departments. 
OTHER EXAMPLES OF NCHHSTP ACTIVITIES 
TO HELP SAVE LIVES:
 ● Issued new guidelines on the treatment of 
latent TB infection, providing guidance 
on administering a new 12-dose regimen 
for TB preventive therapy that significantly 
shortened and simplified the course of 
treatment.  The treatment was the result of 
a clinical trial conducted by the Division of 
TB Elimination’s TB Trials Consortium.
 ● Provided epidemiologic and laboratory 
advice and assistance for numerous out-
breaks of viral hepatitis, including a multi-
state outbreak of hepatitis C centered 
in New Hampshire and  an outbreak of 
hepatitis E infection in large refugee camps 
in Kenya and South Sudan.
 ● Led the successful launch of the first 
National Hepatitis Testing Day, which 
featured well over 100 testing events 
across the country to help identify those 
who are infected and link them to needed 
treatment.
 ● Launched Take Charge, Take the Test, 
a new HIV testing campaign for African 
American women. The campaign was 
launched in 10 target cities where African 
American women are hard hit by HIV. 
“High-Impact HIV Prevention” 
http://www.cdc.gov/about/grand-rounds/ 
archives/2012/August2012.htm
“The Growing Threat of Multidrug-Resistant Gonorrhea” 
http://www.cdc.gov/about/grand-rounds/ 
archives/2012/May2012.htm
“TB and HIV: A Deadly Duo” 
http://www.cdc.gov/about/grand-rounds/ 
archives/2011/March2011.htm
“Chlamydia Prevention: Challenges and Strategies for 
Reducing Disease Burden” 
http://www.cdc.gov/about/grand-rounds/
archives/2010/05-May.htm
“Targeted Paths to HIV Prevention, December 2010” 
http://www.cdc.gov/about/grand-rounds/
archives/2010/12-December.htm
NCHHSTP PARTICIPATES IN CDC PUBLIC 
HEALTH GRAND ROUNDS WEBCASTS
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PROTECTING PEOPLE
CDC RECOMMENDATIONS EXPAND  
HEPATITIS C TESTING 
CDC issued new recommendations for hepatitis C testing that call for a one-time routine hepatitis C testing for all baby 
boomers—people born between 1945 and 1965. 
People in this age group account for more than 75 
percent of adults infected with hepatitis C in the 
United States, and are five times more likely to be 
infected than other adults. Most of those who are 
infected are not aware of their infection because 
hepatitis C can damage the liver for many years 
without noticeable symptoms. More than 15,000 
Americans—mostly baby boomers—die from hepa-
titis C each year from related illnesses—including 
liver cancer and cirrhosis. The new recommenda-
tions were developed by NCHHSTP’s Division of 
Viral Hepatitis.
An estimated 3.2 million Americans are infected 
with hepatitis C and, previously, CDC recom-
mended testing only individuals with certain known 
risk factors. CDC estimates that one-time hepatitis 
C testing of baby boomers could identify more 
than 800,000 additional people with hepatitis C. 
With newly available therapies that can cure up to 
75 percent of infections, expanded testing, along 
with linkage to appropriate care and treatment, 
could save more than 120,000 lives. 
NEW GONORRHEA TREATMENT  
GUIDELINES ISSUED
Gonorrhea is one of the most common STDs in the 
United States, with more than 700,000 infections 
occurring each year. Left untreated, gonorrhea can 
cause serious health problems—particularly for 
women—such as chronic pelvic pain, life-threaten-
ing ectopic pregnancy, and infertility. Infection also 
increases the risk of contracting and transmitting 
HIV. 
To address increases in drug-resistant gonorrhea, 
NCHHSTP published updated gonorrhea treat-
ment guidelines which no longer recommend an 
exclusively oral treatment regimen. The change was 
prompted by trends in laboratory data showing 
that cefixime is becoming less effective in treating 
gonorrhea. 
The updated guidelines recommend a dual therapy 
of injectable ceftriaxone in combination with a 
second antibiotic. Ceftriaxone is more potent 
against gonorrhea than the once-recommended 
oral antibiotic cefixime and, when paired with the 
additional oral antibiotic, might slow the emer-
gence of drug resistance.
NCHHSTP also developed a response plan which 
offers steps state and local health departments 
can take to keep a watchful eye on the emergence 
of drug resistance. In addition to monitoring drug 
resistance nationally, NCHHSTP is working with 
WHO to monitor emerging resistance globally, 
and collaborating with the National Institutes for 
Health to test new combinations of existing drugs.
CDC GUIDES PHYSICIANS ON USE  
OF PREP
Pre-exposure prophylaxis, or PrEP, is a prevention 
method that involves people without HIV infection 
taking daily antiretroviral medication to prevent 
HIV. In 2012, CDC issued interim guidance for 
physicians on PrEP for heterosexuals. This guid-
ance was based on the results of two large interna-
tional clinical trials in which PrEP was found to sig-
nificantly reduce the risk of HIV infection through 
heterosexual sex. The guidance supplements 
existing CDC PrEP interim guidance for MSM, and 
is designed to ensure that physicians who prescribe 
PrEP have accurate information about its safe and 
effective use. NCHHSTP research—particularly the 
TDF2 Study in Botswana conducted in partnership 
with the Botswana Ministry of Health—served as 
the foundation for the clinical guidance.
OTHER EXAMPLES OF NCHHSTP ACTIVITIES 
AIMED AT PROTECTING PEOPLE INCLUDE:
 ● Launching a pilot project designed to test 
new approaches to address the HIV preven-
tion needs of young MSM—a population that 
is among those most at risk for HIV. DASH is 
collaborating with partners in San Francisco, 
New York City, and Philadelphia. The project 
will address HIV prevention strategies for young 
black and Latino MSM, including increased HIV 
testing and treatment and implementation of a 
social marketing campaign.
 ● Initiating Community Approaches to Reducing 
Sexually Transmitted Diseases (CARS). This 
3-year project will use community engage-
ment methods and partnerships to build local 
STD prevention and control capacity. Awards 
were made to the University of  Texas Health 
Science Center in San Antonio, the Virginia 
State Department of Health, the Urban Affairs/
Youth Outreach Adolescent Community Aware-
ness Program in Philadelphia, and the Health 
Research Association Inc., in Los Angeles.  
A total of $5.4 million was awarded for a 
3-year period. 
 ● Providing up-to-date information on HIV, viral 
hepatitis, STDs, and TB via the CDC Web site. 
The STD section is one of the most frequently 
visited sections of CDC.gov. 
 ● Releasing Parent Engagement: Strategies for 
Involving Parents in School Health, which 
describes strategies and action steps for  
connecting with parents, engaging parents in 
school health activities, and sustaining parental 
engagement. The publication includes stories 
from the field showing strategies schools have 
used to engage parents in health promotion   
http://www.cdc.gov/healthyyouth/ 
AdolescentHealth/pdf/parent_engagement_
strategies.pdf.
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PROMOTING HEALTH  
EQUITY
Also included among these projects is a new, 
multi-lingual campaign designed to increase 
awareness and encourage hepatitis B testing 
among Asian Americans and the Know More 
Hepatitis campaign. Education and training mate-
rials for health care professionals to enhance their 
knowledge of hepatitis B and C are also funded. 
INCREASING IMPACT OF HIV PREVENTION FOR 
RACIAL AND ETHNIC MINORITIES
Using funds made available to CDC through the 
Secretary of Health and Human Services’ Minor-
ity AIDS Initiative, NCHHSTP made awards to 
eight state health departments under its Funding 
Opportunity Announcement—Care and Prevention 
in the United States (CAPUS)—in 2012. Addressing 
social determinants of health is a key focus of the 
awards.
 A total of $44.2 million in CAPUS funds is 
estimated to be available over a 3-year period to 
expand HIV prevention services for minority com-
munities with a high HIV disease burden, a dispro-
portionate rate of AIDS diagnoses and associated 
mortality, and an evident effect of social and struc-
tural determinants of health. These awards are 
designed to promote a partnership between health 
departments and those high-prevalence communi-
ties to increase testing, linkage to, and retention in 
care among racial and ethnic minorities. CAPUS 
grantees will also use their funding to address 
some of the most critical social determinants of 
health that affect access to HIV prevention and 
care among these populations.
FIGHTING STIGMA AND COMPLACENCY WITH A 
NEW CAMPAIGN
In July 2012, NCHHSTP announced the nation-
wide launch of Let’s Stop HIV Together—a new 
HIV awareness and anti-stigma campaign featur-
ing individuals with HIV who share their personal 
stories along with their friends and family, and call 
on Americans to help stop the spread of HIV. It 
is reaching millions of Americans through print, 
online, and outdoor advertisements, and through 
social media such as Facebook and Twitter. 
NCHHSTP strives to reduce health dispari-ties in HIV/AIDS, viral hepatitis, STDs and TB by promoting health equity. Health eq-
uity is a key focus of NCHHSTP’s prevention, poli-
cies, and research programs and is one of the six 
goals of NCHHSTP’s Strategic Plan. Health equity 
focuses on the distribution of resources and other 
processes that drive a particular kind of health 
disparity—a systematic inequality in health or in its 
social determinants such as poverty, unequal ac-
cess to health care, lack of education, racism, and 
stigma. Some examples of recent activities that aim 
to address health equity by focusing on popula-
tions disproportionately affected by these diseases 
are listed below. 
RAISING AWARENESS OF HEPATITIS B AND C 
AMONG AFFECTED POPULATIONS
Asian and Pacific Islanders (APIs) make up less 
than 5% of the total population in the United 
States, but account for more than 50% of Ameri-
cans living with chronic hepatitis B. Approximately 
1 in 12 APIs is living with chronic hepatitis B, but 
most of those infected do not know it. Despite 
these high rates, many APIs are not tested for 
hepatitis B. As a result, chronic hepatitis B and 
associated liver cancer in APIs is one of the most 
serious health disparities in the United States.
NCHHSTP awarded nearly $10 million from 
the Affordable Care Act’s Prevention and Public 
Health Fund in 2012. These funds support projects 
that will encourage earlier diagnosis of hepatitis 
B and hepatitis C to help infected people get into 
needed care and raise awareness among Asian 
Americans and other populations who are most 
affected. 
To help address the challenges of chronic viral 
hepatitis infection, NCHHSTP awarded funding 
to 32 organizations to expand testing for hepatitis 
B and hepatitis C and enhance linkage to care, 
treatment, and prevention for those found to be 
infected. These new hepatitis prevention projects 
will also target baby boomers to encourage testing 
for hepatitis C and Asian Americans to be tested 
for hepatitis B.
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In addition to fight-
ing stigma, Let’s Stop 
HIV Together combats 
complacency by 
showing that the HIV 
epidemic touches every 
corner of America, 
regardless of race, 
gender, or sexual orien-
tation. The campaign 
is part of NCHHSTP’s 
Act Against AIDS 
Initiative—a 5-year 
national communica-
tion effort that seeks 
to draw attention 
to the AIDS crisis in 
the United States 
and advance the goals of the National HIV/AIDS 
Strategy.  
In its first 3 months, the Let’s Stop HIV Together 
campaign garnered more than 318 million 
impressions through extensive ad placement and 
outreach in 17 cities across the United States. 
The campaign received coverage in more than 
40 different print, online, and broadcast media 
outlets, including USA Today, ABCNews.com, and 
NBCNews.com. Campaign videos received more 
than 587,000 views on YouTube. 
HIGHLIGHTING YOUTH RISK BEHAVIORS AND 
DISPARITIES
In 2012, NCHHSTP released the 2011 Youth Risk 
Behavior Surveillance System summary, which 
included data on the prevalence of youth risk  
behaviors across the nation in 43 states and 21 
cities. Also released at the same time were 1,019 
different fact sheets that made these data more 
relevant and actionable for states and cities. Many 
of these fact sheets highlighted racial and ethnic 
disparities in the prevalence of youth  
risk behaviors.  
YRBS data released at the International AIDS 
Conference showed that the number of black high 
school students engaging in sexual risk behaviors 
for HIV has declined dramatically in 20 years—sig-
nificantly reducing the disparities in risk between 
black youth and youth of other racial or ethnic 
groups. In 1991, black students were nearly two-
thirds more likely to have had sexual intercourse 
and almost three times as likely to report having 
multiple partners, as compared with white stu-
dents. By 2011, the disparity between black and 
white students who had ever engaged in sex was 
cut in half, and the difference in the likelihood of 
having multiple sex partners declined even more 
(58 percent). However, black students still con-
tinued to report higher levels of sexual risk behav-
ior than their white or Hispanic peers, with the 
exception of reporting significantly higher levels of 
condom use. 
The number of states and cities participating in 
YRBS that included questions on their surveys 
about students’ sexual identity or the sex of their 
sexual contacts increased from 15 in the 2009 
YRBS report to 25 in the 2011 YRBS report.  
This progress will greatly strengthen DASH’s efforts 
to analyze data that highlight the many health risk 
behavior disparities experienced by sexual minority 
youth.  
OTHER EXAMPLES OF NCHHSTP ACTIVITIES 
AIMED AT PROMOTING HEALTH EQUITY:
 ● Held a Youth HIV/STD Prevention and Sexual 
Health External Expert Review, which brought 
experts to Atlanta to discuss NCHHSTP’s youth 
portfolio. 
 ● Launched a Spanish TB website. The website 
targets the general public and provides a variety 
of basic Spanish-language TB information on 
exposure, testing, and treatment. The site  
includes translated fact sheets, publications, 
and posters, as well as recorded video and 
audio podcasts.
 ● Held a series of community engagement ses-
sions with various health department officials 
and community leaders nationwide to discuss 
the disproportionate burden of the HIV/AIDS 
epidemic and STDs among young MSM. The 
purpose of these sessions was to give local 
leadership and community members the oppor-
tunity to speak directly to CDC leadership 
regarding strategies to best address the ongoing 
HIV/AIDS epidemic, STDs, and other sexual 
health-related issues among MSM of color. 
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BUDGET
Figure 1: NCHHSTP Domestic Program Budget FY 2008-2012
Except for domestic 
HIV/AIDS and viral 
hepatitis prevention 
and research, appro-
priations for NCHH-
STP’s programs have 
remained relatively 
stable over the past 
5 years.
Notes: FY 2010 HIV amount includes $30 million from the Affordable Care 
Act’s Prevention and Public Health Fund (ACA/PPHF). FY 2012 VH amount 
includes $10 million from ACA/PPHF. FY 2011 and 2012 HIV amounts 
reflect the transfer of HIV school health funding to NCHHSTP.
Except for domestic HIV/AIDS and viral hepatitis prevention and research, appropriations for NCHHSTP’s 
programs have remained relatively stable over the past 5 years.
Figure 2: FY 2012 NCHHSTP Performance Indicators (35 total) All Divisions & Programs
NCHHSTP reports on 35 performance measures in its annual budget request to Congress. These measure 
help CDC assess the extent to which our efforts in HIV/AIDS, viral hepatitis, STD, and TB prevention result 
in real changes in health. CDC anticipates reporting on a greater proportion of measures in the future.
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